Insider Transactions in Q2 2025 at Liquidia Corp (LQDA)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 28
2025
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
455
-0.25%
|
$6,370
$14.24 P/Share
|
|
Apr 21
2025
|
Rajeev Saggar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,450
-0.92%
|
$31,850
$13.67 P/Share
|
|
Apr 15
2025
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,406
-1.56%
|
$44,278
$13.57 P/Share
|
|
Apr 14
2025
|
Roger Jeffs Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,130
-1.38%
|
$183,690
$13.57 P/Share
|
|
Apr 14
2025
|
Russell Schundler General Counsel |
SELL
Open market or private sale
|
Direct |
5,964
-1.03%
|
$77,532
$13.57 P/Share
|
|
Apr 14
2025
|
Rajeev Saggar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,714
-1.38%
|
$48,282
$13.57 P/Share
|
|
Apr 14
2025
|
Michael Kaseta CFO and COO |
SELL
Open market or private sale
|
Direct |
8,283
-2.05%
|
$107,679
$13.57 P/Share
|
|
Apr 14
2025
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
1,856
-1.0%
|
$24,128
$13.57 P/Share
|
|
Apr 11
2025
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,906
+2.06%
|
-
|